Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: * In previous work, we showed a long-term and concentration-dependent beneficial effect of the non-nucleoside reverse transcriptase inhibitor efavirenz (EFV) on high-density lipoproteins (HDL) in human immunodeficiency virus (HIV)-infected patients. * Furthe...
Main Author: | |
---|---|
Other Authors: | , , , , , , |
Format: | article |
Language: | eng |
Published: |
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/10400.10/399 |
Country: | Portugal |
Oai: | oai:repositorio.hff.min-saude.pt:10400.10/399 |